December 8, 2014

NBTY on Monday announced the appointment of Brian Wynne to the role of president of NBTY Americas, and CEO of its U.S. subsidiary - United States Nutrition.

December 8, 2014

President Barack Obama signed into law in late November the Sunscreen Innovation Act.

December 5, 2014

RetailNext on Thursday reported a decrease in U.S. store sales of 11% on a 11.4% decline in store traffic for the retail calendar month ending Nov. 29. 

 

December 3, 2014

Health-and-wellness companies see increasing opportunity in the point-of-care channel to reach and engage with patients primed to receive information about their health.

 

December 1, 2014

ComScore on Sunday reported that U.S. desktop retail e-commerce spending for the first 28 days of the 2014 holiday season were up 15% to $22.7 billion. 

December 1, 2014

Teva Pharmaceutical on Monday announced the launch of a generic version of Exforge HCT (amlodipine, valsartan, hydrochlorothiazide) tablets in the United States. 

December 1, 2014

Walmart on Friday reported a robust Thanksgiving Day as part of its ongoing 2014 holiday sales season. 

November 24, 2014

Rite Aid on Monday announced that many of its 4,600 locations will be open 8 a.m. to 5 p.m. on Thanksgiving Day, and will be opening 7 a.m. on Black Friday.

November 24, 2014

Walgreens on Monday reported a perfect score of 100% on the 2015 Corporate Equality Index.

November 21, 2014

According to reports, House Republicans filed a lawsuit Friday charging the Obama administration with overreaching in the implementation of the Affordable Care Act. 

November 20, 2014

Walgreens may be in a year of transition through 2015.

 

November 20, 2014

Decision Resources Group found that sales of biosimilar versions of the granulocyte colony-stimulating factors (G-CSFs) filgrastim and pegfilgrastim could reach $1.8 billion in the United States by 2023. 

November 20, 2014

Dr. Reddy’s Labs announced Thursday that it has launched a bioequivalent generic version of Allegra-D 12 Hour Allergy and Congestion, in the U.S. market.

November 20, 2014

More specialty drug innovation, greater patient access to medicines and reduced impact from patent expiries will be the primary drivers of an increase in global medicine spending of up to 30% by 2018.

November 20, 2014

Purdue Pharma on Thursday announced that the Food and Drug Administration approved Hysingla ER (hydrocodone bitartrate) extended‐release tablets CII, a once‐daily, single‐entity medication formulated using Purdue’s proprietary extended‐release solid oral platform, Resistec.

November 19, 2014

L'Oreal Paris USA has tapped Genesis Rodriguez as the brand's newest ambassador.

November 19, 2014

MinuteClinic has opened New Mexico's first retail medical clinics inside three CVS/pharmacy stores in Albuquerque and one in Rio Rancho.

November 19, 2014

Walgreens opened its first location here in the Alaska Interior on Tuesday, according to a report in the Fairbanks Daily News-Miner.

November 18, 2014

CVS Health officially announced plans to create a new Digital Innovation Lab in Boston.

November 17, 2014

Four-in-10 U.S. adults are expected to develop Type 2 diabetes at some point in their lifetime, according to a new study published in The Lancet Diabetes & Endocrinology in August, suggesting that as many as 126 million consumers will be looking for treatment options, including self-monitoring their condition at home.

November 17, 2014

Genzyme, a Sanofi company, on Friday announced that the Food and Drug Administration approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis. 

November 17, 2014

DSN spoke with Neas in late October to mark the 30th anniversary of the landmark Drug Price Competition and Patent Term Restoration Act — better known as the Hatch-Waxman Act. 

November 17, 2014

Target and Kaiser Permanente are teaming up to launch in Southern California four Target Clinics that will feature expanded services not typically available in Target Clinics.

November 17, 2014

In response to the growing popularity of soft drinks sweetened with cane sugar and the spike in demand for “MexiCoke,” Coke has started distributing the product itself in the United States.